Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jan 7, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.2K

Plant-Derived Antioxidants as Modulators of Redox Signaling and Epigenetic Reprogramming in Cancer.

Thi Thuy Truong1, Alka Ashok Singh2, Soonhyuk Tak1

  • 1Industry 4.0 Convergence Bionics Engineering, Department of Biomedical Engineering, Pukyong National University, Busan 48513, Republic of Korea.

Cells
|December 24, 2025
PubMed
Summary

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

7.6K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
7.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Epigenetic Regulation01:37

Epigenetic Regulation

3.7K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.7K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

18.3K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
18.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Indole-Derived Compounds as Redox-Modulators: Antioxidant Mechanisms in Neuronal Protection.

Molecules (Basel, Switzerland)·2026
Same author

Role of Microbial Toxins in Neurodegenerative Diseases: Insights and Future Perspectives.

Biomolecules·2026
Same author

Biomaterial Strategies for Three-Dimensional Bioprinting and Drug Delivery Application.

Materials (Basel, Switzerland)·2026
Same author

A Novel Approach Combining Ultrasound-Induced Drug-Free Vasodilation and Photoacoustic Monitoring of Vascular Responses.

Annals of biomedical engineering·2026
Same author

MXene-based hybrid nanocomposites for enhanced enzyme-electrode electron transfer for high-performance glucose biosensing.

Bioelectrochemistry (Amsterdam, Netherlands)·2026
Same author

Decoding chemical composition of urinary crystals from ultrasonic echo signals via deep learning.

Mikrochimica acta·2026

Plant-derived antioxidants combat cancer by regulating reactive oxygen species (ROS) and reversing epigenetic changes. These natural compounds show promise as adjuncts in precision oncology, enhancing cancer therapies.

Area of Science:

  • Oncology
  • Epigenetics
  • Natural Product Chemistry

Background:

  • Cancer progression involves redox imbalance and epigenetic dysregulation.
  • Reactive oxygen species (ROS) play dual roles in cancer, promoting growth at moderate levels and apoptosis at high levels.
  • Oxidative stress impacts histone modifications, DNA methylation, and non-coding RNA expression, supporting malignant phenotypes.

Purpose of the Study:

  • To review the dual role of plant-derived antioxidants in cancer biology.
  • To explore their mechanisms in modulating redox balance and epigenetic landscape.
  • To discuss their potential as adjuncts in precision oncology.

Main Methods:

  • Literature review of studies on plant-derived antioxidants and cancer.
  • Analysis of mechanisms involving ROS scavenging, redox balance restoration, and epigenetic modulation.
Keywords:
ROS modulationcancer therapyepigenetic reprogrammingplant-derived antioxidantsredox signaling

More Related Videos

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula
09:03

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula

Published on: January 26, 2024

645

Related Experiment Videos

Last Updated: Jan 7, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.2K
Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula
09:03

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula

Published on: January 26, 2024

645
  • Examination of specific compounds like resveratrol, curcumin, EGCG, quercetin, and sulforaphane.
  • Main Results:

    • Plant antioxidants act as dual modulators, scavenging ROS, restoring redox balance, and reversing epigenetic alterations.
    • Compounds like resveratrol and EGCG modulate DNA methyltransferases (DNMTs), histone deacetylases (HDACs), and non-coding RNA networks.
    • These antioxidants can enhance the efficacy of chemotherapy and radiation therapy.

    Conclusions:

    • Plant-derived antioxidants hold significant potential as precision oncology adjuncts.
    • Challenges in translational efficacy, dosing, and bioavailability require further research.
    • Biomarker-guided strategies and nano-delivery systems are crucial for clinical translation.